Orabloc Forte (Articaine Hydrochloride, Epinephrine)

Articaine blocks voltage‑gated sodium channels on nerve fibers, preventing the initiation and propagation of action potentials. This interruption of nerve signaling results in loss of sensation. Epinephrine in the formulation causes local vasoconstriction, limiting systemic absorption and extending the duration of anesthesia.

The dose of Orabloc Forte is determined by the prescribing dental professional based on the specific procedure, patient age, weight, and health status. Only a qualified practitioner should calculate and administer the appropriate volume to ensure safety and efficacy.

Safety data for articaine during pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Clinicians should discuss the risks and alternatives with pregnant or nursing patients before treatment.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Compared with lidocaine, articaine has a higher lipid solubility, allowing faster onset and deeper penetration into bone. The addition of epinephrine further extends its duration. However, clinicians must consider individual patient factors, such as allergy history and cardiovascular status, when selecting the most appropriate anesthetic.

Orabloc Forte should be stored at 2‑8 °C in a refrigerator, protected from light, and kept in its original packaging. Do not freeze or shake the vial. If the product reaches room temperature, it may be used for a limited period, but re‑refrigeration is recommended for long‑term stability.

The solution is administered by a trained dental professional via intra‑oral injection into the targeted tissue area. Proper aseptic technique and appropriate needle selection are essential. The anesthetic effect typically begins within minutes and lasts for the duration required for the procedure.

Serious risks include allergic reactions such as anaphylaxis, severe cardiovascular events like hypertension or tachycardia due to epinephrine, seizures, methemoglobinemia, and prolonged nerve block. Immediate medical attention is required if any of these symptoms occur after administration.

Patients with a known hypersensitivity to articaine, other amide‑type local anesthetics, or epinephrine should avoid this product. It is also contraindicated in individuals with uncontrolled hypertension, certain cardiac arrhythmias, or those taking non‑selective MAO inhibitors without appropriate medical supervision.